Cell therapies are revolutionizing the treatment of disease and are poised to transform health outcomes. Advances in biology and technology have enabled the development of innovation in a more distributed way than ever before: there is a wave of novel therapeutics in academic centers and biotechs around the world looking for partners to advance their inventions. That’s where we come in. Our approach is to bring clinical stage therapies through late stage development and commercialization by partnering with innovators at academic medical centers and small biotechs around the world. Headquartered in San Francisco, CA, the company is backed by seed investment from National Resilience, Inc., Hibiscus BioVentures, and Jumpstart Nova, as well as several high-net-worth individuals.